Home ⟩ Insights

Insights

fda

4 min read • May 22, 2024

Cannabis Rescheduling Signals Strong Returns, Tax Breaks Could Increase This Stock’s Market Cap By 170%

17 min read • May 12, 2024

Mitch McConnell’s Cannabis Gambit: How The Farm Bill Unwittingly Fueled A THC Boom

4 min read • April 30, 2024

The Medical Cannabis Explosion Just Got Real

2 min read • April 23, 2024

This Pharma Co. Kicks Off FDA Approval Process For CBD-Based Treatment Of Chronic Pain

4 min read • April 13, 2024

Analyst Reacts To FDA Commish Comments: Medical And Recreational Cannabis Could Have Separate Regulations

3 min read • April 12, 2024

FDA Commissioner To House Committee: ‘There’s No Reason For DEA To Delay’ Cannabis Rescheduling

1 min read • April 11, 2024

‘FDA Head Says There’s ‘No Reason For DEA To Delay’ Rescheduling Marijuana’ – Marijuana Moment

4 min read • March 21, 2024

VP Harris, DEA, FDA Eye Cannabis: Key Changes Ahead, Here’s What One Expert Predicts

4 min read • March 15, 2024

VP Kamala Harris Urges DEA To Reschedule Cannabis ‘As Quickly As Possible,’ Calls Prohibition ‘Absurd’ & ‘Unfair’

3 min read • March 14, 2024

GOP Sen. John Cornyn Takes Health Secretary To Task Over Cannabis Rescheduling: Xavier Becerra Holds His Own

2 min read • February 29, 2024

Kratom, CBD, Marijuana: Regulatory Update, Get Tuned In Under 2 Minutes

5 min read • February 27, 2024

Why Cannabis Decontamination Is An Instrumental Part Of The Post-Harvest Process

Latest Headlines

6 min read • September 1, 2026

Germany Just Ended Insurance Coverage for Cannabis Flower. Most Patients Will Keep Buying, but Not at the Price Insurers Were Paying.

4 min read • August 31, 2026

Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 2

5 min read • August 31, 2026

Glass House, America’s Largest Cannabis Grower by Canopy, Rings the NYSE Bell

6 min read • August 31, 2026

USCR Urges Congress to Keep the Hemp Loophole Closed

4 min read • August 28, 2026

Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 1

3 min read • August 28, 2026

$10 Million in Taxpayer Money Was Diverted Into Florida’s Fight Against Marijuana Legalization, Grand Jury Says

2 min read • August 28, 2026

PharmaCielo Revenue Surges 330%; European Cannabis Flower Sales Take Off

5 min read • August 27, 2026

Massachusetts Could Kill Its $1.6 Billion Cannabis Market and Close 300+ Stores, CEO Warns

2 min read • August 27, 2026

IM Cannabis Implements 30-for-1 Reverse Stock Split as It Fights to Maintain Nasdaq Listing

4 min read • August 26, 2026

Four Things Nobody Told You About the DEA Cannabis Hearings — But You Probably Wanted to Ask

3 min read • August 26, 2026

Financial Times: Germany’s Cannabis Imports Surge Sixfold, Regulatory Pressure Mounts

3 min read • August 25, 2026

Comply With What? Hemp Ban Nears; the FDA Leaves Industry Waiting for Answers

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

california cannabis

cannabis cultivation

cannabis earnings

Christopher Dillis

Congress cannabis

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

first quarter earnings

germany cannabis

hemp legalization

hemp regulation

IgniteIt Events

illegal cannabis farms

intoxicating hemp-derived products

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

UC Berkeley Cannabis Research Center

unlicensed cannabis

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.